nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CA14—Furosemide—dilated cardiomyopathy	0.109	0.124	CbGbCtD
Methazolamide—CA6—Furosemide—dilated cardiomyopathy	0.104	0.118	CbGbCtD
Methazolamide—CA5A—Furosemide—dilated cardiomyopathy	0.104	0.118	CbGbCtD
Methazolamide—CA7—Furosemide—dilated cardiomyopathy	0.0905	0.103	CbGbCtD
Methazolamide—CA5B—Furosemide—dilated cardiomyopathy	0.0905	0.103	CbGbCtD
Methazolamide—CA12—Furosemide—dilated cardiomyopathy	0.0776	0.0881	CbGbCtD
Methazolamide—CA9—Furosemide—dilated cardiomyopathy	0.0776	0.0881	CbGbCtD
Methazolamide—CA1—Furosemide—dilated cardiomyopathy	0.0726	0.0824	CbGbCtD
Methazolamide—CA4—Furosemide—dilated cardiomyopathy	0.0683	0.0775	CbGbCtD
Methazolamide—CA2—Furosemide—dilated cardiomyopathy	0.0628	0.0713	CbGbCtD
Methazolamide—SLC22A6—Furosemide—dilated cardiomyopathy	0.0242	0.0274	CbGbCtD
Methazolamide—CA5B—sinoatrial node—dilated cardiomyopathy	0.0185	0.428	CbGeAlD
Methazolamide—CYP2C9—cardial valve—dilated cardiomyopathy	0.00947	0.219	CbGeAlD
Methazolamide—Metabolic acidosis—Furosemide—dilated cardiomyopathy	0.00404	0.0533	CcSEcCtD
Methazolamide—Appetite absent—Lisinopril—dilated cardiomyopathy	0.00241	0.0318	CcSEcCtD
Methazolamide—CA14—cardiac ventricle—dilated cardiomyopathy	0.00235	0.0544	CbGeAlD
Methazolamide—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00199	0.0262	CcSEcCtD
Methazolamide—Glycosuria—Furosemide—dilated cardiomyopathy	0.00197	0.026	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00192	0.0253	CcSEcCtD
Methazolamide—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00178	0.0234	CcSEcCtD
Methazolamide—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00164	0.0217	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00163	0.0215	CcSEcCtD
Methazolamide—CA14—heart—dilated cardiomyopathy	0.00155	0.0357	CbGeAlD
Methazolamide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00153	0.0202	CcSEcCtD
Methazolamide—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.0015	0.0198	CcSEcCtD
Methazolamide—Urine output increased—Furosemide—dilated cardiomyopathy	0.00144	0.019	CcSEcCtD
Methazolamide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00139	0.0184	CcSEcCtD
Methazolamide—CA14—cardiac atrium—dilated cardiomyopathy	0.00132	0.0305	CbGeAlD
Methazolamide—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00132	0.0174	CcSEcCtD
Methazolamide—Polyuria—Furosemide—dilated cardiomyopathy	0.00132	0.0174	CcSEcCtD
Methazolamide—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00128	0.0169	CcSEcCtD
Methazolamide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00119	0.0157	CcSEcCtD
Methazolamide—Malaise—Spironolactone—dilated cardiomyopathy	0.00116	0.0153	CcSEcCtD
Methazolamide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00115	0.0151	CcSEcCtD
Methazolamide—CA4—cardiac ventricle—dilated cardiomyopathy	0.00114	0.0263	CbGeAlD
Methazolamide—CA5B—heart—dilated cardiomyopathy	0.00108	0.025	CbGeAlD
Methazolamide—Discomfort—Spironolactone—dilated cardiomyopathy	0.00108	0.0142	CcSEcCtD
Methazolamide—CA4—myocardium—dilated cardiomyopathy	0.00107	0.0247	CbGeAlD
Methazolamide—Confusional state—Spironolactone—dilated cardiomyopathy	0.00106	0.0139	CcSEcCtD
Methazolamide—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00105	0.0138	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00104	0.0138	CcSEcCtD
Methazolamide—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000991	0.0131	CcSEcCtD
Methazolamide—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000968	0.0128	CcSEcCtD
Methazolamide—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000964	0.0127	CcSEcCtD
Methazolamide—CA1—heart—dilated cardiomyopathy	0.000955	0.0221	CbGeAlD
Methazolamide—CA2—cardiac ventricle—dilated cardiomyopathy	0.000942	0.0218	CbGeAlD
Methazolamide—Somnolence—Spironolactone—dilated cardiomyopathy	0.000931	0.0123	CcSEcCtD
Methazolamide—CA5B—cardiac atrium—dilated cardiomyopathy	0.000925	0.0214	CbGeAlD
Methazolamide—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000915	0.0121	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000904	0.0119	CcSEcCtD
Methazolamide—Drowsiness—Furosemide—dilated cardiomyopathy	0.000893	0.0118	CcSEcCtD
Methazolamide—CA2—myocardium—dilated cardiomyopathy	0.000886	0.0205	CbGeAlD
Methazolamide—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000886	0.0117	CcSEcCtD
Methazolamide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000863	0.0114	CcSEcCtD
Methazolamide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000834	0.011	CcSEcCtD
Methazolamide—Urticaria—Spironolactone—dilated cardiomyopathy	0.000832	0.011	CcSEcCtD
Methazolamide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000828	0.0109	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000783	0.0103	CcSEcCtD
Methazolamide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000758	0.01	CcSEcCtD
Methazolamide—Tinnitus—Furosemide—dilated cardiomyopathy	0.000748	0.00986	CcSEcCtD
Methazolamide—CA4—heart—dilated cardiomyopathy	0.000746	0.0172	CbGeAlD
Methazolamide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000717	0.00945	CcSEcCtD
Methazolamide—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000714	0.00942	CcSEcCtD
Methazolamide—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000686	0.00905	CcSEcCtD
Methazolamide—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000684	0.00902	CcSEcCtD
Methazolamide—Vomiting—Spironolactone—dilated cardiomyopathy	0.000666	0.00878	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000665	0.00876	CcSEcCtD
Methazolamide—Rash—Spironolactone—dilated cardiomyopathy	0.00066	0.00871	CcSEcCtD
Methazolamide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00066	0.0087	CcSEcCtD
Methazolamide—Headache—Spironolactone—dilated cardiomyopathy	0.000656	0.00865	CcSEcCtD
Methazolamide—Haematuria—Lisinopril—dilated cardiomyopathy	0.000639	0.00843	CcSEcCtD
Methazolamide—CA4—cardiac atrium—dilated cardiomyopathy	0.000638	0.0147	CbGeAlD
Methazolamide—Vertigo—Furosemide—dilated cardiomyopathy	0.000627	0.00827	CcSEcCtD
Methazolamide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000626	0.00825	CcSEcCtD
Methazolamide—Leukopenia—Furosemide—dilated cardiomyopathy	0.000625	0.00824	CcSEcCtD
Methazolamide—Nausea—Spironolactone—dilated cardiomyopathy	0.000622	0.0082	CcSEcCtD
Methazolamide—CA2—heart—dilated cardiomyopathy	0.000619	0.0143	CbGeAlD
Methazolamide—Confusional state—Furosemide—dilated cardiomyopathy	0.000575	0.00758	CcSEcCtD
Methazolamide—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00057	0.00751	CcSEcCtD
Methazolamide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000569	0.0075	CcSEcCtD
Methazolamide—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000561	0.0074	CcSEcCtD
Methazolamide—Anorexia—Furosemide—dilated cardiomyopathy	0.000543	0.00716	CcSEcCtD
Methazolamide—CA2—cardiac atrium—dilated cardiomyopathy	0.000529	0.0122	CbGeAlD
Methazolamide—CYP2C9—heart—dilated cardiomyopathy	0.000523	0.0121	CbGeAlD
Methazolamide—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000513	0.00677	CcSEcCtD
Methazolamide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000512	0.00675	CcSEcCtD
Methazolamide—Somnolence—Furosemide—dilated cardiomyopathy	0.000507	0.00668	CcSEcCtD
Methazolamide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000495	0.00653	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000492	0.00649	CcSEcCtD
Methazolamide—Fatigue—Furosemide—dilated cardiomyopathy	0.000491	0.00648	CcSEcCtD
Methazolamide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000486	0.00641	CcSEcCtD
Methazolamide—Malaise—Lisinopril—dilated cardiomyopathy	0.000472	0.00623	CcSEcCtD
Methazolamide—Vertigo—Lisinopril—dilated cardiomyopathy	0.000471	0.00621	CcSEcCtD
Methazolamide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00047	0.00619	CcSEcCtD
Methazolamide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000469	0.00618	CcSEcCtD
Methazolamide—Urticaria—Furosemide—dilated cardiomyopathy	0.000453	0.00597	CcSEcCtD
Methazolamide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00045	0.00594	CcSEcCtD
Methazolamide—Discomfort—Lisinopril—dilated cardiomyopathy	0.000441	0.00581	CcSEcCtD
Methazolamide—Confusional state—Lisinopril—dilated cardiomyopathy	0.000431	0.00569	CcSEcCtD
Methazolamide—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000428	0.00564	CcSEcCtD
Methazolamide—Asthenia—Furosemide—dilated cardiomyopathy	0.000409	0.00539	CcSEcCtD
Methazolamide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000408	0.00537	CcSEcCtD
Methazolamide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00039	0.00514	CcSEcCtD
Methazolamide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000384	0.00506	CcSEcCtD
Methazolamide—Somnolence—Lisinopril—dilated cardiomyopathy	0.00038	0.00501	CcSEcCtD
Methazolamide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000376	0.00496	CcSEcCtD
Methazolamide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000372	0.0049	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000369	0.00487	CcSEcCtD
Methazolamide—Fatigue—Lisinopril—dilated cardiomyopathy	0.000369	0.00486	CcSEcCtD
Methazolamide—Vomiting—Furosemide—dilated cardiomyopathy	0.000362	0.00478	CcSEcCtD
Methazolamide—Rash—Furosemide—dilated cardiomyopathy	0.000359	0.00474	CcSEcCtD
Methazolamide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000359	0.00473	CcSEcCtD
Methazolamide—Headache—Furosemide—dilated cardiomyopathy	0.000357	0.00471	CcSEcCtD
Methazolamide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000352	0.00465	CcSEcCtD
Methazolamide—Urticaria—Lisinopril—dilated cardiomyopathy	0.00034	0.00448	CcSEcCtD
Methazolamide—Nausea—Furosemide—dilated cardiomyopathy	0.000338	0.00446	CcSEcCtD
Methazolamide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000338	0.00446	CcSEcCtD
Methazolamide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000307	0.00405	CcSEcCtD
Methazolamide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000293	0.00386	CcSEcCtD
Methazolamide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000272	0.00359	CcSEcCtD
Methazolamide—Rash—Lisinopril—dilated cardiomyopathy	0.00027	0.00356	CcSEcCtD
Methazolamide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000269	0.00355	CcSEcCtD
Methazolamide—Headache—Lisinopril—dilated cardiomyopathy	0.000268	0.00353	CcSEcCtD
Methazolamide—Nausea—Lisinopril—dilated cardiomyopathy	0.000254	0.00335	CcSEcCtD
